目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. INDIA CONTRAST MEDIA MARKET, BY TYPE (USD MILLION)
6.1. Iodinated Contrast Media
6.2. Gadolinium-Based Contrast Media

7. INDIA CONTRAST MEDIA MARKET, BY FORM (USD MILLION)
7.1. Tablet
7.2. Powder
7.3. Liquid
7.4. Paste

8. INDIA CONTRAST MEDIA MARKET, BY PROCEDURE (USD MILLION)
8.1. X-ray/Computed Tomography (CT)
8.2. Magnetic Resonance Imaging (MRI)

9. INDIA CONTRAST MEDIA MARKET, BY APPLICATION (USD MILLION)
9.1. Cardiovascular Disease
9.2. Oncology
9.3. Gastrointestinal Disorders

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market share Analysis
10.4. Major Growth Strategy in the Contrast Media Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Contrast Media Market
10.7. Key developments and growth strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales and Operating Income
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. Radiant Insights
11.1.1. Financial Overview
11.1.2. Products Offered
11.1.3. Key Developments
11.1.4. SWOT Analysis
11.1.5. Key Strategies
11.2. Zydus Cadila
11.2.1. Financial Overview
11.2.2. Products Offered
11.2.3. Key Developments
11.2.4. SWOT Analysis
11.2.5. Key Strategies
11.3. Eastman Chemical Company
11.3.1. Financial Overview
11.3.2. Products Offered
11.3.3. Key Developments
11.3.4. SWOT Analysis
11.3.5. Key Strategies
11.4. Guerbet
11.4.1. Financial Overview
11.4.2. Products Offered
11.4.3. Key Developments
11.4.4. SWOT Analysis
11.4.5. Key Strategies
11.5. Akorn
11.5.1. Financial Overview
11.5.2. Products Offered
11.5.3. Key Developments
11.5.4. SWOT Analysis
11.5.5. Key Strategies
11.6. Toshiba Medical Systems
11.6.1. Financial Overview
11.6.2. Products Offered
11.6.3. Key Developments
11.6.4. SWOT Analysis
11.6.5. Key Strategies
11.7. Fujifilm
11.7.1. Financial Overview
11.7.2. Products Offered
11.7.3. Key Developments
11.7.4. SWOT Analysis
11.7.5. Key Strategies
11.8. Siemens Healthineers
11.8.1. Financial Overview
11.8.2. Products Offered
11.8.3. Key Developments
11.8.4. SWOT Analysis
11.8.5. Key Strategies
11.9. Bracco
11.9.1. Financial Overview
11.9.2. Products Offered
11.9.3. Key Developments
11.9.4. SWOT Analysis
11.9.5. Key Strategies
11.10. Lantheus
11.10.1. Financial Overview
11.10.2. Products Offered
11.10.3. Key Developments
11.10.4. SWOT Analysis
11.10.5. Key Strategies
11.11. Bayer
11.11.1. Financial Overview
11.11.2. Products Offered
11.11.3. Key Developments
11.11.4. SWOT Analysis
11.11.5. Key Strategies
11.12. Bharat Serums and Vaccines
11.12.1. Financial Overview
11.12.2. Products Offered
11.12.3. Key Developments
11.12.4. SWOT Analysis
11.12.5. Key Strategies
11.13. NantWorks
11.13.1. Financial Overview
11.13.2. Products Offered
11.13.3. Key Developments
11.13.4. SWOT Analysis
11.13.5. Key Strategies
11.14. Mallinckrodt
11.14.1. Financial Overview
11.14.2. Products Offered
11.14.3. Key Developments
11.14.4. SWOT Analysis
11.14.5. Key Strategies
11.15. GE Healthcare
11.15.1. Financial Overview
11.15.2. Products Offered
11.15.3. Key Developments
11.15.4. SWOT Analysis
11.15.5. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. INDIA CONTRAST MEDIA MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 3. INDIA CONTRAST MEDIA MARKET SIZE ESTIMATES & FORECAST, BY FORM, 2019-2035 (USD BILLIONS)
TABLE 4. INDIA CONTRAST MEDIA MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD BILLIONS)
TABLE 5. INDIA CONTRAST MEDIA MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 6. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 7. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. INDIA CONTRAST MEDIA MARKET ANALYSIS BY TYPE
FIGURE 3. INDIA CONTRAST MEDIA MARKET ANALYSIS BY FORM
FIGURE 4. INDIA CONTRAST MEDIA MARKET ANALYSIS BY PROCEDURE
FIGURE 5. INDIA CONTRAST MEDIA MARKET ANALYSIS BY APPLICATION
FIGURE 6. KEY BUYING CRITERIA OF CONTRAST MEDIA MARKET
FIGURE 7. RESEARCH PROCESS OF MRFR
FIGURE 8. DRO ANALYSIS OF CONTRAST MEDIA MARKET
FIGURE 9. DRIVERS IMPACT ANALYSIS: CONTRAST MEDIA MARKET
FIGURE 10. RESTRAINTS IMPACT ANALYSIS: CONTRAST MEDIA MARKET
FIGURE 11. SUPPLY / VALUE CHAIN: CONTRAST MEDIA MARKET
FIGURE 12. CONTRAST MEDIA MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 13. CONTRAST MEDIA MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
FIGURE 14. CONTRAST MEDIA MARKET, BY FORM, 2024 (% SHARE)
FIGURE 15. CONTRAST MEDIA MARKET, BY FORM, 2019 TO 2035 (USD Billions)
FIGURE 16. CONTRAST MEDIA MARKET, BY PROCEDURE, 2024 (% SHARE)
FIGURE 17. CONTRAST MEDIA MARKET, BY PROCEDURE, 2019 TO 2035 (USD Billions)
FIGURE 18. CONTRAST MEDIA MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 19. CONTRAST MEDIA MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
FIGURE 20. BENCHMARKING OF MAJOR COMPETITORS